The Central Commission for Discipline Inspection issued a document: to clean up medical corruption, interview dealers.

Medical Network September 4th, the Central Commission for Discipline Inspection issued five times, a thorough investigation of medical corruption September 2nd, the Central Commission for Discipline Inspection, the State Supervision Commission website published "to take the case as a mirror Chengdu seriously rectify the problem of corruption in the medical field" article.
The above shows that the director of the original equipment and materials supply section of the First People's Hospital of Longquan District, Chengdu, took advantage of the convenience of his position and adopted illegal methods to obtain benefits for the relevant personnel in the supply of drugs, equipment procurement and other aspects, accepting bribes of more than 680,000 yuan.
e.g. from 2013 to 2019, the above-mentioned persons helped a medical equipment supplies supplier Shen to continue to undertake medical equipment and supplies business in a district hospital by disclosing the procurement plan and providing tender parameters, and received a total of RMB 1684 million from Shen.
this is the fifth time this year that the Central Commission for Discipline Inspection has issued a message stressing the fight against medical corruption.
August 14, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article entitled "Anti-corruption three people talk about the discipline inspection and supervision group of the Health and Safety Commission: strengthening political supervision and strictly investigating violations of discipline and law", calling for the capture of corruption, focusing on the management of high-value supplies, strict investigation and punishment of violations of discipline and law and other issues.
August 4, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published "Focus areas of positive wind anti-corruption observation deep investigation of medical corruption", said that the medical field should be resolutely investigated and punished serious violations of discipline.
the first half of this year disclosed in the medical field corruption cases, the collection of drug supplies rebates is the most frequent problem, the amount involved in the case remains high, the chain of corrupt interests is chained together.
June 27th, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published the article "Observations on how to deal with bribery in the field of medicine and bribery together", which refers directly to the pharmaceutical industry to recover deductions, take commissions, thank you fees and other acts.
article shows that there are pharmaceutical representatives admitted that the use of drug prices around 45% rebate, soliciting secondary agents in hospital relations to open sales channels.
April 3, the website of the State Supervision Commission of the Central Commission for Discipline Inspection published an article on the article "Trafficking in Pharmaceutical Data, Secretly Making Drug Generations", revealing the case involving pharmaceutical sales personnel for profit.
Dealers, department heads were interviewed about the above-mentioned serious violations of discipline and law cases, Chengdu Commission for Discipline Inspection, the relevant person in charge said, on the one hand, its own problems, on the other hand, from the responsibility, system, supervision, education and other aspects to analyze the root causes of the problem.
Chengdu Commission for Discipline Inspection supervision committee urged the relevant units to carry out to promote reform, one by one, from the source to prevent the problem from happening again.
Chengdu Longquan District, the first people's hospital related to the introduction, July 20, the hospital organized a 2020 drug supplier management and integrity work interview, the dynamic monitoring of drug use found significant fluctuations in the amount of seven drug distribution companies to interview, requiring them to abide by the commitment to regulate the operation.
also held a surgical supplies distributor communication meeting, to further improve the acceptance of surgical supplies and access to the library process, in the ERP system to enable the "operating room sales warehouse, special purchase goods access to the library process."
In the next 4 days, the above-mentioned hospitals again on the dynamic monitoring of drug dosing found significant fluctuations in dosing of the five clinical department heads to remind the conversation, called for strengthening the supervision of drug use in the department, to prevent risks.
Chengdu Commission for Discipline Inspection, the relevant person in charge of the introduction, from the recent investigation and prosecution of the health and health industry areas, in the bidding or procurement process through the transfer of benefits, covert operations, false price increases and other violations of discipline and law is particularly prominent, while medical institutions responsible for supplies, drugs, equipment procurement of key posts corruption problems prone to multiple.
some medical institutions unreasonable drug use, unreasonable inspection and inspection, unreasonable use of high-value medical supplies and other phenomena also occur from time to time.
to this end, Chengdu to the city at all levels of various medical institutions, as well as secondary and above public medical institutions, maternal and child health care institutions, social-run medical institutions as the focus, focusing on 6 months to carry out health and health industry areas outstanding problems of special rectification.
Highlight key units, key departments, pay close attention to key groups, key posts, focus on the rectification of illegal selection, private procurement, billing, excessive use, first use, storage, commercial control and other illegal acts, focusing on the abuse, counterfeiting, false accounting, misrecording and other unreasonable use of consumables and excessive use, targeted use, fingerless use and other unreasonable drug use.
To take the volume of procurement as the cut entrance, correct rebates for the problem of pharmaceutical corruption, Guangxi Medical University affiliated oncology hospital related to the person in charge of the article analysis, pharmaceutical products from the production to the hands of patients in the production of drugs, pricing, bidding, doctors prescription (use), patient purchase of each link may be corruption.
For example, for the pricing of pharmaceutical products, the sale of ordinary, substitute products, do not have a competitive advantage of the product, it is necessary to set the price high, in the sale of more profits to achieve.
part of the policy system loopholes, through the declaration of new drugs to achieve independent pricing.
Through centralized bidding procurement also seems to have problems, the above article analysis, the bidding company will take from the winning drug price of about 8% of the profits;
The relevant researchers of China Pharmaceutical University have published the "Research on the formation mechanism of the phenomenon of "Giffinization" in China's public hospital drug market, showing that china's public hospital pharmaceutical market presents the following four main characteristics: 1, the market supply is fully competitive;
The pharmaceutical market in public hospitals does not follow the most basic economic principles in the theory of price equilibrium, such as "oversupply prices rise, oversupply prices fall" and "the cheaper the price, the greater the sales volume".
, China's drug demand has risen as prices have risen, i.e. the demand curve has sloped positively.
this is similar to the supply and demand mechanism of the "Giffin commodity" market proposed in economics.
Liu Pengcheng, a project researcher at the National Center for Drug Policy and Pharmaceutical Industry Economics at China Pharmaceutical University, has analyzed Seberan devices mainly because product users and selectors in the pharmaceutical industry are separated - consumers pay, but they can't decide which consumables or drugs to use.
The above article shows that the key to solve this problem is to cut off the chain of interests between physicians and products, doctors do not assume the "sales" function, do not get "kickbacks" and other gray income from product consumption, then it can eliminate the doctor through the drug supplies profit transmission to obtain consumer surplus value, its motivation to pursue high-priced drug supplies will naturally disappear.
and volume procurement is to solve this problem, doctors no longer have the choice of drugs and supplies, how much to use at how much price, health insurance bureau and other relevant departments have clear rules.
the main body of the purchase, drugs and consumables will gradually return to normal market behavior, the lower the price competition.
.